Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Survey highlights interest in diet’s effects on RA
RA symptoms may be directly affected by diet.
Article
Multiple myeloma: Lenalidomide approved as maintenance therapy after auto-HSCT
The Food and Drug Administration has approved the use of lenalidomide (Revlimid) for maintenance therapy following autologous hematopoietic stem...
News
Urgent colonoscopy for LGIB: Consider case by case
Compared with elective colonoscopy, urgent colonoscopy for lower GI bleeding may be safe but might not be worth the rush.
News
PADI2: A potential therapeutic target in multiple myeloma?
Researchers have identified a novel mechanism by which increased expression of peptidyl arginine deiminase 2 (PADI2) by bone marrow mesenchymal...
News
Scalp cooling reduces hair loss in 50% or more of women in separate studies
Scalp cooling resulted in significant reductions in hair loss in about half of all women who were treated before, during, and after chemotherapy...
News
Reversion mutations detected in cfDNA could guide HGSC treatment
BRCA1/2 reversion mutations that restore protein function and lead to clinically significant rates of acquired resistance can be detected in an...
News
Specific polymorphisms excluded in hemophilic arthropathy
Blood sample findings dispute a suspected genetic link to arthropathy in patients with severe or moderate hemophilia A or B.
News
Low inhibitor incidence seen with new generation rhFVIII
A new generation recombinant factor VIII of human origin appears to be associated with a low inhibitor incidence in patients with severe...
News
Study highlights importance of genotyping in von Willebrand disease
Patients with genetically confirmed von Willebrand disease of this type have a relatively mild clinical phenotype.
News
Solulin variants activate TAFI in vitro
A new generation of solulin variants is showing promise in the treatment of severe hemophilia A.
News
Boys with severe hemophilia have good physical function
Children with severe hemophilia have generally good self-reported health-related quality of life and physical functioning, but one issue in...
News
ITI protects against bleeding in hemophilia A with factor VIII inhibitors
Immune tolerance induction in hemophilia A patients with inhibitor development against FVIII may provide some protection against bleeding.
News
Study: No link between vaccines, inhibitor development
Pediatric vaccinations given near the time of factor VIII exposure are not linked with inhibitor development in patients with severe hemophilia A...
News
AHEAD studies establish bleed rate benchmarks
More than 37% of patients who had moderate or severe hemophilia A and were on prophylaxis experienced less than one bleed per year on average, and...
News
In active CLL with deletion 17p, consider trial enrollment
NEW YORK – Outside of clinical trials, therapy for early stage chronic lymphocytic leukemia in patients with deletion of the short arm of...